Daniel Abraham Carlton, MD
Otolaryngology · Roseville
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 3
- Since medical school
- 13 years
- University of Chicago, Pritzker School of Medicine, 2013
Offices
3 locations · Sacramento Ear Nose and Throat Surgical and Medical Group Inc · 29 clinicians in this group
Hospitals listed: Sutter Auburn Faith Hospital · Sutter Roseville Medical Center. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Carlton’s office to ask if they take your plan before you enroll.
California Medical Board record
Licence A162302 · Current
Licensed to practise in California · since 2019 · expires 2027-05-31 · University of Chicago, Pritzker School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Surgery centers they own
- South Placer Surgery Center LP dba Sutter Sierra Surgery CenterAmbulatory Surgery Center · Roseville, CA1.01% owner since 2021 · accredited by AAAHCAccreditation Renewed5 inspections, 2 with deficiencies · last 2024-01-22
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Otolaryngology - Otolaryngology
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Sutter Auburn Faith HospitalAuburn, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 4 of 5 · 79% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0, Oct 2024 – Sep 2025
- Sutter Roseville Medical CenterRoseville, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 4 of 5 · 79% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Pressure ulcer rate: 0.08 (0 to 0.56) · 12,400 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.069, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.262, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.128, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.357, Oct 2024 – Sep 2025
See every measure and the patient survey for Sutter Auburn Faith Hospital
Behind the star rating — Deaths: 0 better, 6 the same, 0 worse of 6 measures. Safety: 1 better, 4 the same, 0 worse of 5 measures. Readmissions: 3 better, 6 the same, 0 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.96 (0 to 2.01) · 312 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.04 (0.62 to 1.46) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 160.66 (100.73 to 220.58) · 26 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 9.5 · 63 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 12.7 · 160 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 16 · 241 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.6 · 105 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.9 · 1,272 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.19 (0 to 0.42) · 2,484 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.29 (0.08 to 0.5) · 2,442 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.11 (1.72 to 6.49) · 442 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.61 (0 to 3.31) · 130 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.12 (0.47 to 3.78) · 417 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.72 (0.67 to 18.77) · 133 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 8.26 (4.11 to 12.4) · 113 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.68 (0.18 to 3.18) · 135 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.33 (0 to 1.3) · 1,845 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.4 · 34 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.2 · 215 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.9 · 178 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -30.1 · 250 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.1 · 300 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.5 (3.5 to 8.5) · 58 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 11.6 (8 to 16.4) · 58 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.4 · 32 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 18.8 · 95 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 11.7 (9 to 15.2) · 1,787 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.3) · 473 cases | No different | Jan 2024 – Dec 2024 |
What patients said (563 patients answered, 27% of those asked)
| Cleanliness | 5 |
| Nurse communication | 5 |
| Doctor communication | 4 |
| Communication about medicines | 4 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 81% |
| Nurses "always" communicated well | 83% |
| Doctors "always" communicated well | 84% |
| Staff "always" explained | 66% |
| Yes, staff "did" give patients this information | 90% |
| Yes, staff "did" give patients information about help after discharge | 91% |
| Doctors "always" explained things so they could understand | 81% |
| Doctors "always" listened carefully | 82% |
| Doctors "always" treated them with courtesy and respect | 89% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 79% |
| Nurses "always" explained things so they could understand | 80% |
| Nurses "always" listened carefully | 81% |
| Nurses "always" treated them with courtesy and respect | 89% |
| "Always" quiet at night | 51% |
| "YES", patients would definitely recommend the hospital | 79% |
| Staff "always" explained possible side effects | 53% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
See every measure and the patient survey for Sutter Roseville Medical Center
Behind the star rating — Deaths: 2 better, 5 the same, 0 worse of 7 measures. Safety: 5 better, 1 the same, 1 worse of 7 measures. Readmissions: 2 better, 7 the same, 1 worse of 10 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Pressure ulcer rateComplications and deaths | 0.08 (0 to 0.56) · 12,400 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.069 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.262 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.128 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.357 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.33 (0.49 to 2.17) · 2,916 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.9 (0.63 to 1.17) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 147.2 (107.33 to 187.07) · 191 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 7.9 · 250 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.7 · 484 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.4 · 839 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13.3 · 1,027 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10 · 656 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.8 · 6,822 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.25 (0.08 to 0.42) · 14,300 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.23 (0.06 to 0.41) · 14,490 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.43 (2.77 to 6.08) · 3,117 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.38 (0 to 2.95) · 938 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.06 (0.76 to 3.36) · 2,944 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.03 (2.8 to 15.25) · 840 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.43 (3.11 to 9.75) · 899 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.73 (0.34 to 3.11) · 819 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.4 · 35 cases | None | Apr 2023 – Mar 2025 |
| SSI - Colon SurgeryInfections | 0.41 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.9 · 527 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.6 · 1,094 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -16.6 · 443 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -11 · 961 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -8 · 1,064 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.1 · 1,293 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.5 (3.5 to 8.7) · 35 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.2 (6.9 to 14.9) · 35 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.4 · 36 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 18.5 · 310 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.2 (9.8 to 17.9) · 116 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.8 (0.7 to 1) · 1,600 cases | No different | Jan 2024 – Dec 2024 |
What patients said (537 patients answered, 24% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 74% |
| Nurses "always" communicated well | 80% |
| Doctors "always" communicated well | 77% |
| Staff "always" explained | 62% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 70% |
| Doctors "always" listened carefully | 76% |
| Doctors "always" treated them with courtesy and respect | 84% |
| Patients who gave a rating of "9" or "10" (high) | 77% |
| Staff "always" explained new medications | 77% |
| Nurses "always" explained things so they could understand | 78% |
| Nurses "always" listened carefully | 75% |
| Nurses "always" treated them with courtesy and respect | 86% |
| "Always" quiet at night | 52% |
| "YES", patients would definitely recommend the hospital | 79% |
| Staff "always" explained possible side effects | 47% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$190,880
Medicare paid this office $190,880 for 595 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Diagnostic exam of nasal passages using an endoscope | 205 | $49,915 | $157 |
| Short return visit (20+ min) | 191 | $20,672 | $68 |
| New patient visit (30+ min) | 252 | $20,581 | $82 |
| New patient visit (45+ min) | 140 | $15,928 | $114 |
| Return visit (30+ min) | 118 | $14,103 | $97 |
See all 19 services
| Diagnostic exam of nasal passages using an endoscope | 205 | $49,915 | $157 |
| Short return visit (20+ min) | 191 | $20,672 | $68 |
| New patient visit (30+ min) | 252 | $20,581 | $82 |
| New patient visit (45+ min) | 140 | $15,928 | $114 |
| Return visit (30+ min) | 118 | $14,103 | $97 |
| Biopsy or removal of nasal polyp or tissue using an endoscope | 27 | $11,763 | $256 |
| Diagnostic exam of voice box using a flexible endoscope | 101 | $11,527 | $102 |
| Comprehensive hearing and speech recognition test | 244 | $7,062 | $28 |
| Test to assess middle ear function | 256 | $3,533 | $13 |
| Exam of ear using a microscope | 134 | $3,113 | $22 |
| Ct scan of face without contrast | 26 | $3,068 | $114 |
| Removal of nasal sinus tissue using an endoscope | 13 | $3,036 | $234 |
| Computer-assisted procedure outside membrane covering brain | 15 | $2,048 | $137 |
| Removal of impacted cerumen (one or both ears) by physician on same date of service as audiologic function testing | 50 | $1,774 | $35 |
| Removal of impacted ear wax | 39 | $1,763 | $35 |
| Test to assess balance during warm and cool irrigation in both ears | 15 | $401 | $27 |
| Test for abnormal eye movement using 3 positions with recording | 16 | $311 | $19 |
| Test for abnormal eye movement with recording | 16 | $272 | $17 |
| Test for abnormal eye movement using a moving target that moves back and forth with recording | 16 | $192 | $12 |
Procedures year by year
| Procedure | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Diagnostic exam of nasal passages using an endoscope | 18 | 165 | 191 | 245 | 259 | 318 |
| Diagnostic exam of voice box using a flexible endoscope | 13 | 36 | 37 | 59 | 86 | 113 |
| Biopsy or removal of nasal polyp or tissue using an endoscope | – | 48 | 49 | 58 | 61 | 46 |
| Removal of impacted ear wax | – | 19 | 50 | 44 | 68 | 50 |
| Removal of nasal sinus tissue using an endoscope | – | 15 | – | 12 | 20 | 13 |
| Computer-assisted procedure outside membrane covering brain | – | 17 | – | – | 21 | 15 |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
595 Original Medicare patients in 2024. Average age 75 · Under 65 5% · 85 and older 13% · Women 59% · Also on Medicaid 13% · Health risk score 1.01. At or below the middle of the specialty; the typical otolaryngology clinician is at 1.19.
Conditions among them: High blood pressure 72% · Diabetes 26% · Coronary heart disease 25% · Chronic kidney disease 21% · Depression 21% · Atrial fibrillation 18% · Cancer 16% · COPD 15% · Heart failure 12% · Stroke 8% · Dementia 4%.
The office billed $820,808, Medicare allowed $259,016 and paid $190,880; for 2,276 services of 56 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 595 | 2,276 | 75 | 1.01 | $820,808 | $190,880 |
| 2023 | 559 | 2,162 | 75 | 1.02 | $807,621 | $187,938 |
| 2022 | 411 | 1,718 | 74 | 1.03 | $652,968 | $149,000 |
| 2021 | 382 | 1,333 | 73 | 1.04 | $510,973 | $126,071 |
| 2020 | 283 | 1,007 | 73 | 1.06 | $481,706 | $106,683 |
| 2019 | 99 | 247 | 71 | 1.19 | $76,394 | $18,912 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 16 services
| Diagnostic exam of nasal passages using an endoscope | 168 | $40,893 | $158 |
| New patient visit (30+ min) | 242 | $20,069 | $83 |
| Short return visit (20+ min) | 191 | $19,135 | $67 |
| New patient visit (45+ min) | 133 | $16,822 | $126 |
| Biopsy or removal of nasal polyp or tissue using an endoscope | 31 | $16,485 | $270 |
| Return visit (30+ min) | 101 | $14,818 | $101 |
| Diagnostic exam of voice box using a flexible endoscope | 73 | $9,337 | $109 |
| Comprehensive hearing and speech recognition test | 212 | $6,795 | $29 |
| Removal of tissue from sphenoid sinus using an endoscope | 11 | $5,194 | $472 |
| Removal of nasal sinus tissue using an endoscope | 20 | $4,285 | $214 |
| Exam of ear using a microscope | 134 | $3,835 | $24 |
| Test to assess middle ear function | 208 | $3,101 | $13 |
| Computer-assisted procedure outside membrane covering brain | 21 | $2,938 | $140 |
| Removal of impacted ear wax | 50 | $2,277 | $33 |
| Ct scan of face without contrast | 19 | $2,210 | $116 |
| Removal of impacted cerumen (one or both ears) by physician on same date of service as audiologic function testing | 55 | $2,177 | $39 |
2022: 19 services
| Diagnostic exam of nasal passages using an endoscope | 145 | $38,277 | $156 |
| New patient visit (30+ min) | 224 | $17,386 | $78 |
| Short return visit (20+ min) | 152 | $15,903 | $68 |
| Biopsy or removal of nasal polyp or tissue using an endoscope | 30 | $14,927 | $257 |
| Return visit (30+ min) | 81 | $13,611 | $101 |
| New patient visit (45+ min) | 55 | $6,608 | $120 |
| Diagnostic exam of voice box using a flexible endoscope | 43 | $6,028 | $102 |
| Comprehensive hearing and speech recognition test | 165 | $5,038 | $29 |
| Removal of nasal sinus tissue using an endoscope | 12 | $2,692 | $224 |
| Exam of ear using a microscope | 87 | $2,429 | $24 |
| Test to assess middle ear function | 148 | $2,147 | $13 |
| Ct scan of face without contrast | 18 | $2,142 | $113 |
| Removal of impacted ear wax | 33 | $1,561 | $35 |
| Removal of impacted cerumen (one or both ears) by physician on same date of service as audiologic function testing | 35 | $1,426 | $40 |
| Test to assess balance during warm and cool irrigation in both ears | 14 | $451 | $32 |
| Test for eardrum and muscle function | 23 | $434 | $18 |
| Test for abnormal eye movement using 3 positions with recording | 15 | $344 | $23 |
| Test for abnormal eye movement with recording | 15 | $299 | $20 |
| Test for abnormal eye movement using a moving target that moves back and forth with recording | 15 | $199 | $13 |
2021: 14 services
| Diagnostic exam of nasal passages using an endoscope | 125 | $32,581 | $171 |
| New patient visit (30+ min) | 216 | $17,535 | $81 |
| Short return visit (20+ min) | 137 | $15,234 | $72 |
| Biopsy or removal of nasal polyp or tissue using an endoscope | 14 | $13,461 | $275 |
| Return visit (30+ min) | 44 | $7,616 | $104 |
| New patient visit (45+ min) | 43 | $5,629 | $131 |
| Diagnostic exam of voice box using a flexible endoscope | 32 | $3,892 | $105 |
| Comprehensive hearing and speech recognition test | 97 | $3,074 | $31 |
| Ct scan of face without contrast | 24 | $2,709 | $113 |
| Removal of impacted ear wax | 41 | $1,668 | $33 |
| Exam of ear using a microscope | 53 | $1,431 | $23 |
| Test to assess middle ear function | 97 | $1,384 | $14 |
| Removal of impacted cerumen (one or both ears) by physician on same date of service as audiologic function testing | 34 | $1,362 | $40 |
| Short return visit | 18 | $920 | $42 |
2020: 15 services
| Diagnostic exam of nasal passages using an endoscope | 109 | $26,701 | $162 |
| New patient visit (30+ min) | 165 | $12,593 | $76 |
| Biopsy or removal of nasal polyp or tissue using an endoscope | 21 | $12,212 | $254 |
| Return visit (30+ min) | 58 | $9,171 | $87 |
| Short return visit (20+ min) | 79 | $5,359 | $53 |
| New patient visit (45+ min) | 40 | $4,616 | $115 |
| Diagnostic exam of voice box using a flexible endoscope | 31 | $3,699 | $103 |
| Removal of nasal sinus tissue using an endoscope | 15 | $3,692 | $246 |
| Computer-assisted procedure outside membrane covering brain | 17 | $2,454 | $144 |
| Comprehensive hearing and speech recognition test | 64 | $1,835 | $28 |
| Exam of ear using a microscope | 39 | $1,154 | $24 |
| Removal of impacted cerumen (one or both ears) by physician on same date of service as audiologic function testing | 19 | $641 | $34 |
| Removal of impacted ear wax | 18 | $595 | $31 |
| Test for eardrum and muscle function | 38 | $586 | $15 |
| Test to assess middle ear function | 35 | $475 | $14 |
2019: 7 services
| New patient visit (30+ min) | 64 | $5,483 | $86 |
| Diagnostic exam of nasal passages using an endoscope | 16 | $3,057 | $170 |
| Short return visit (20+ min) | 21 | $1,659 | $61 |
| New patient visit (45+ min) | 11 | $1,488 | $135 |
| Diagnostic exam of voice box using a flexible endoscope | 13 | $1,280 | $98 |
| Comprehensive hearing and speech recognition test | 30 | $925 | $31 |
| Test for eardrum and muscle function | 26 | $457 | $18 |
Medicaid work
$15,770 in 2024
Medicaid paid $15,770 for 280 billed services this clinician did in 2024, up to 21 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| New patient visit (30+ min) | 88 | $6,917 |
| Nasal endoscopy, diagnostic, unilateral or bilateral (separate procedure) | 61 | $3,457 |
| Comprehensive audiometry threshold evaluation and speech recognition | 37 | $1,676 |
| Short return visit (20+ min) | 54 | $1,670 |
| New patient visit (45+ min) | 13 | $1,440 |
| Tympanometry and reflex threshold measurements | 14 | $425 |
| Binocular microscopy | 13 | $185 |
| 2024 | 280 | 7 | 21 | $15,770 |
| 2023 | 134 | 3 | 19 | $962 |
| 2022 | 287 | 6 | 20 | $5,766 |
| 2021 | 534 | 8 | 24 | $17,369 |
| 2020 | 717 | 9 | 25 | $21,605 |
| 2019 | 295 | 5 | 41 | $5,928 |
See the largest Medicaid services in earlier years
2023
| Nasal endoscopy, diagnostic, unilateral or bilateral (separate procedure) | 95 | $735 |
| Short return visit (20+ min) | 27 | $150 |
| New patient visit (30+ min) | 12 | $76 |
2022
| Short return visit (20+ min) | 86 | $2,619 |
| Nasal endoscopy, diagnostic, unilateral or bilateral (separate procedure) | 75 | $1,971 |
| Return visit (30+ min) | 29 | $390 |
| Comprehensive audiometry threshold evaluation and speech recognition | 24 | $283 |
| OFFICE/OP CONSLTJ NEW/EST PT LOW MDM 30 MINUTES | 25 | $260 |
| Tympanometry and reflex threshold measurements | 48 | $243 |
2021
| New patient visit (30+ min) | 116 | $8,307 |
| Short return visit (20+ min) | 134 | $4,174 |
| Nasal endoscopy, diagnostic, unilateral or bilateral (separate procedure) | 129 | $3,614 |
| Comprehensive audiometry threshold evaluation and speech recognition | 37 | $336 |
| Return visit (30+ min) | 13 | $310 |
| Binocular microscopy | 30 | $224 |
| Tympanometry and reflex threshold measurements | 34 | $210 |
| OFFICE/OP CONSLTJ NEW/EST PT LOW MDM 30 MINUTES | 41 | $194 |
2020
| New patient visit (30+ min) | 128 | $9,298 |
| Nasal endoscopy, diagnostic, unilateral or bilateral (separate procedure) | 137 | $7,017 |
| Return visit (30+ min) | 63 | $2,168 |
| Short return visit (20+ min) | 63 | $950 |
| Tympanometry and reflex threshold measurements | 105 | $810 |
| Comprehensive audiometry threshold evaluation and speech recognition | 54 | $789 |
| OFFICE/OP CONSLTJ NEW/EST PT LOW MDM 30 MINUTES | 119 | $395 |
| Binocular microscopy | 13 | $177 |
| Additional supplies, materials, and clinical staff time over and above those usually included in an office visit or other non-facility service(s), when performed during a Public Health Emergency, as defined by law, due to respiratory-transmitted infectious disease | 35 | $0 |
2019
| New patient visit (30+ min) | 70 | $4,050 |
| Nasal endoscopy, diagnostic, unilateral or bilateral (separate procedure) | 36 | $1,255 |
| Comprehensive audiometry threshold evaluation and speech recognition | 53 | $414 |
| Tympanometry and reflex threshold measurements | 66 | $209 |
| OFFICE/OP CONSLTJ NEW/EST PT LOW MDM 30 MINUTES | 70 | $0 |
Drugs they prescribed that Part D paid
$42,406
Pharmacies billed $42,406 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 6% of their Part D prescriptions (37 of 586) in 2024. Above the middle of the specialty; the typical otolaryngology clinician is at 4%.
546 generic and 40 brand-name prescriptions · $42,406 in drug cost · 106 antibiotic prescriptions to 64 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Xhance | 37 | $30,312 | $819 |
| Azelastine | 98 | $3,074 | $31 |
| Ipratropium | 78 | $1,772 | $23 |
| Fluocinolone Acetonide Oil | 25 | $923 | $37 |
| Ofloxacin | 16 | $862 | $54 |
See all 14 drugs
| Xhance | 37 | $30,312 | $819 |
| Azelastine | 98 | $3,074 | $31 |
| Ipratropium | 78 | $1,772 | $23 |
| Fluocinolone Acetonide Oil | 25 | $923 | $37 |
| Ofloxacin | 16 | $862 | $54 |
| Fluticasone Propionate | 28 | $468 | $17 |
| Amoxicillin-Clavulanate Potass | 39 | $463 | $12 |
| Mupirocin | 48 | $386 | $8 |
| Doxycycline Hyclate | 28 | $342 | $12 |
| Oxycodone-Acetaminophen | 34 | $150 | $4 |
| Sulfamethoxazole-Trimethoprim | 15 | $144 | $10 |
| Prednisone | 47 | $132 | $3 |
| Triamcinolone Acetonide | 14 | $60 | $4 |
| Montelukast | 11 | $0 | $0 |
Year by year
| 2024 | 586 | 194 | 6% (37) | 7% | $42,406 |
| 2023 | 467 | 180 | 6% (29) | 7% | $39,524 |
| 2022 | 452 | 160 | 6% (25) | 8% | $33,542 |
| 2021 | 386 | 133 | 5% (19) | 4% | $20,012 |
| 2020 | 212 | 83 | 9% (20) | None | $6,980 |
| 2019 | 33 | 20 | None | None | $807 |
| 2018 | 21 | 15 | None | 0% | $701 |
| 2017 | 43 | 24 | 28% (12) | None | $1,120 |
| 2016 | 36 | 25 | 44% (16) | None | $1,409 |
| 2014 | 27 | 16 | None | 48% | $6,364 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 13 drugs
| Xhance | 29 | $28,329 | $977 |
| Azelastine | 61 | $2,775 | $45 |
| Ipratropium | 61 | $1,952 | $32 |
| Fluocinolone Acetonide Oil | 20 | $833 | $42 |
| Fluticasone Propionate | 26 | $604 | $23 |
| Amoxicillin-Clavulanate Potass | 41 | $554 | $14 |
| Mupirocin | 43 | $522 | $12 |
| Doxycycline Hyclate | 15 | $325 | $22 |
| Sulfamethoxazole-Trimethoprim | 23 | $273 | $12 |
| Omeprazole | 13 | $221 | $17 |
| Prednisone | 42 | $210 | $5 |
| Oxycodone-Acetaminophen | 22 | $108 | $5 |
| Triamcinolone Acetonide | 14 | $87 | $6 |
2022: 11 drugs
| Xhance | 29 | $18,654 | $643 |
| Azelastine | 68 | $2,707 | $40 |
| Ipratropium | 51 | $2,248 | $44 |
| Fluocinolone Acetonide Oil | 17 | $1,507 | $89 |
| Fluticasone Propionate | 46 | $794 | $17 |
| Amoxicillin-Clavulanate Potass | 32 | $686 | $21 |
| Mupirocin | 40 | $430 | $11 |
| Doxycycline Hyclate | 12 | $166 | $14 |
| Prednisone | 43 | $149 | $3 |
| Sulfamethoxazole-Trimethoprim | 22 | $141 | $6 |
| Oxycodone-Acetaminophen | 19 | $95 | $5 |
2021: 9 drugs
| Azelastine | 81 | $2,648 | $33 |
| Ipratropium | 38 | $1,905 | $50 |
| Fluocinolone Acetonide Oil | 21 | $1,156 | $55 |
| Fluticasone Propionate | 54 | $896 | $17 |
| Ofloxacin | 14 | $809 | $58 |
| Amoxicillin-Clavulanate Potass | 32 | $795 | $25 |
| Mupirocin | 18 | $212 | $12 |
| Prednisone | 45 | $165 | $4 |
| Oxycodone-Acetaminophen | 17 | $135 | $8 |
2020: 6 drugs
| Azelastine | 28 | $1,356 | $48 |
| Doxycycline Hyclate | 17 | $582 | $34 |
| Fluticasone Propionate | 19 | $518 | $27 |
| Amoxicillin-Clavulanate Potass | 31 | $366 | $12 |
| Oxycodone-Acetaminophen | 20 | $214 | $11 |
| Prednisone | 34 | $126 | $4 |
2017: 1 drug
| Oxycodone-Acetaminophen | 12 | $74 | $6 |
Money from drug and device companies
$535 in 2025
| 2025 | 4 | 5 | None | $535 |
| 2024 | 2 | 3 | None | $320 |
| 2023 | 3 | 3 | None | $69 |
| 2022 | 2 | 3 | None | $55 |
| 2021 | 1 | 2 | None | $116 |
| 2020 | 7 | 15 | $5,130 | $7,149 |
| 2019 | 4 | 8 | None | $354 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Cochlear Americas | Cochlear Nucleus Ci632 Cochlear Implant With Slim Modiolar Electrode | $310 | 2 payments
|
| Aerin Medical | Vivaer Stylus | $183 | 1 payment
|
| Medtronic | Propel | $23 | 1 payment
|
| GlaxoSmithKline | Nucala | $19 | 1 payment
|
See all 5 published payments
| Cochlear Americas | Meals · 2025-11-20 | Cochlear Nucleus Ci632 Cochlear Implant With Slim Modiolar Electrode | $150 |
| Cochlear Americas | Meals · 2025-11-20 | Cochlear Nucleus Ci632 Cochlear Implant With Slim Modiolar Electrode | $160 |
| GlaxoSmithKline | Meals · 2025-10-15 | Nucala | $19 |
| Aerin Medical | Meals · 2025-05-15 | Vivaer Stylus | $183 |
| Medtronic | Meals · 2025-03-21 | Propel | $23 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $320
| Inspire Medical Systems | Inspire | $200 | 2 payments
|
| Genzyme | Dupixent | $120 | 1 payment
|
2023: $69
| Inspire Medical Systems | Inspire | $27 | 1 payment
|
| GlaxoSmithKline | Nucala | $22 | 1 payment
|
| Stryker | Xpress Ent Dilation System | $21 | 1 payment
|
2022: $55
| GlaxoSmithKline | Nucala | $30 | 2 payments
|
| OptiNose US | Xhance | $25 | 1 payment
|
2021: $116
| Stryker | Navsuite | $116 | 2 payments
|
2020: $7,149
| Genentech USA | Xolair | $6,859 | 4 payments
|
| Aerin Medical | Vivaer | $92 | 2 payments
|
| Intersect ENT | Sinuva | $81 | 3 payments
|
| OptiNose US | Xhance | $61 | 3 payments
|
| Genzyme | Dupixent | $23 | 1 payment
|
| Regeneron Healthcare Solutions | Dupixent | $22 | 1 payment
|
| Smith+Nephew | Tula System | $11 | 1 payment
|
2019: $354
| Intersect ENT | Sinuva | $244 | 4 payments
|
| OptiNose US | Xhance | $43 | 2 payments
|
| Aerin Medical | Vivaer Rf Stylus | $34 | 1 payment
|
| Stryker | Clarifix | $33 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 68.0 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1760725683
- Licence
- CA A162302, MO 2018010590California A162302: Current · expires 2027-05-31
- Trained
- University of Chicago, Pritzker School of Medicine, 2013 · 13 years ago
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Otolaryngology (207Y00000X); Federal specialty code 207YX0007X (207YX0007X); Student in a training program (390200000X)
- Mailing address
- 1111 Exposition Blvd Bldg 700, Sacramento, CA, 95815
- NPI first listed
- 2013-03-28
- NPI last updated
- 2020-11-03
- NPI record certified
- 2020-11-03
This is when the NPI record was last certified, not a medical board exam.